Company / Operating Cash Flow per Share
KalVista Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.60
FY2025
5-year range
-$4.38 / -$2.43
FY2021-FY2025
Trend
-16.8%
vs FY2024
Sector context
#179 of 212
Health Care
What the data says
KalVista Pharmaceuticals, Inc.'s operating cash flow per share of $-3.60 is lower than 84% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-5.11 in FY2016 to $1.02 in FY2017.
Based on SEC 10-K filings.
-3.60 in FY2025.
Declined from $-2.43 to $-3.60 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-168.1% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 16.8% year-over-year.
- Ranks #179 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2017.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.60 | -16.8% |
| FY2024 | -$3.08 | -27.0% |
| FY2023 | -$2.43 | +21.3% |
| FY2022 | -$3.08 | +29.6% |
| FY2021 | -$4.38 | -150.7% |
| FY2020 | -$1.75 | +20.5% |
| FY2019 | -$2.20 | -62.2% |
| FY2018 | -$1.35 | -232.4% |
| FY2017 | $1.02 | +120.0% |
| FY2016 | -$5.11 | +89.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026